Methylprednisolone Sodium Succinate, a potent glucocorticoid medication with a wide range of clinical applications.
Basic Information
English Name: Methylprednisolone Sodium Succinate
CAS Number: 2375-03-3
Molecular Formula: C26H33NaO8
Molecular Weight: 496.53
Pharmacological Action
Mechanism of Action: Methylprednisolone Sodium Succinate acts as a glucocorticoid receptor (GR) agonist, exhibiting immunosuppressive and anti-inflammatory activities. In vivo, it converts to active prednisolone, activating GR-mediated gene expression.
Anti-inflammatory Effect: Compared to prednisolone, Methylprednisolone Sodium Succinate exhibits stronger anti-inflammatory effects with weaker water and sodium retention, making it more effective and less prone to side effects in treating various inflammatory diseases.
Indications
Methylprednisolone Sodium Succinate is widely used in the treatment of multiple diseases, including but not limited to:
Severe Allergic Reactions: Such as anaphylactic shock, severe bronchial asthma, etc.
Autoimmune Diseases: Like rheumatoid arthritis, systemic lupus erythematosus, etc.
Hematological Disorders: Such as aplastic anemia, leukemia, etc.
Gastrointestinal Diseases: Including ulcerative colitis, Crohn's disease, etc.
Endocrine Disorders: Like hypopituitarism, adrenal insufficiency, etc.
